Total Payments
$22,534
2024 Payments
$2,544
Companies
59
Transactions
1,431
Medicare Patients
2,266
Medicare Billing
$574,468
Payment Breakdown by Category
Food & Beverage$21,929 (97.3%)
Education$605.13 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,929 | 1,415 | 97.3% |
| Education | $605.13 | 16 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,292 | 256 | $0 (2024) |
| ABBVIE INC. | $2,109 | 119 | $0 (2024) |
| PFIZER INC. | $1,708 | 103 | $0 (2024) |
| UCB, Inc. | $1,674 | 89 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,554 | 130 | $0 (2024) |
| Janssen Biotech, Inc. | $1,439 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,301 | 73 | $0 (2024) |
| Genentech USA, Inc. | $1,135 | 79 | $0 (2024) |
| Lilly USA, LLC | $727.14 | 39 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $646.45 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,544 | 147 | Amgen Inc. ($283.47) |
| 2023 | $2,876 | 162 | UCB, Inc. ($330.45) |
| 2022 | $3,228 | 189 | Amgen Inc. ($546.55) |
| 2021 | $3,076 | 202 | Amgen Inc. ($649.67) |
| 2020 | $2,350 | 151 | Amgen Inc. ($612.97) |
| 2019 | $3,055 | 200 | Novartis Pharmaceuticals Corporation ($438.56) |
| 2018 | $2,894 | 196 | Janssen Biotech, Inc. ($658.19) |
| 2017 | $2,512 | 184 | Genentech USA, Inc. ($300.89) |
All Payment Transactions
1,431 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $40.01 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $8.57 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $6.51 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Analgesic | ||||||
| 10/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Immunology | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Immunology | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 599 | 5,649 | $355,611 | $151,584 |
| 2022 | 13 | 555 | 5,046 | $338,794 | $138,938 |
| 2021 | 12 | 567 | 5,891 | $402,657 | $152,242 |
| 2020 | 12 | 545 | 5,603 | $308,423 | $131,703 |
Total Patients
2,266
Total Services
22,189
Medicare Billing
$574,468
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 48 | 4,500 | $190,890 | $82,031 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 467 | $93,400 | $41,126 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $17,877 | $7,596 | 42.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 56 | $17,584 | $6,030 | 34.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 44 | 88 | $9,134 | $4,610 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,191 | $1,977 | 47.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 145 | $6,380 | $1,698 | 26.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 13 | 62 | $4,340 | $1,464 | 33.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 31 | 31 | $3,100 | $1,247 | 40.2% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 19 | 19 | $1,639 | $1,039 | 63.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 33 | 165 | $3,300 | $1,008 | 30.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $1,884 | $831.97 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,644 | $819.29 | 49.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 16 | 19 | $247.00 | $107.94 | 43.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 39 | 3,900 | $165,438 | $66,633 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 471 | $94,200 | $42,189 | 44.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 29 | 101 | $31,714 | $11,743 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $13,938 | $5,719 | 41.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 38 | 59 | $6,124 | $3,227 | 52.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,953 | $2,131 | 43.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 15 | 80 | $6,600 | $1,975 | 29.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 15 | 25 | $4,270 | $1,557 | 36.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 28 | 28 | $2,800 | $1,109 | 39.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 44 | 89 | $3,916 | $1,062 | 27.1% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 29 | 145 | $2,800 | $767.82 | 27.4% |
About Dr. David Korman, MD
Dr. David Korman, MD is a Rheumatology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245297555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Korman, MD has received a total of $22,534 in payments from pharmaceutical and medical device companies, with $2,544 received in 2024. These payments were reported across 1,431 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($21,929).
As a Medicare-enrolled provider, Korman has provided services to 2,266 Medicare beneficiaries, totaling 22,189 services with total Medicare billing of $574,468. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Denver, CO
- Active Since 04/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1245297555
Products in Payments
- Enbrel (Biological) $1,919
- Cimzia (Drug) $1,622
- COSENTYX (Biological) $1,335
- BENLYSTA (Biological) $1,286
- XELJANZ (Drug) $1,258
- SIMPONI ARIA (Biological) $1,089
- ACTHAR (Biological) $988.37
- Rituxan (Biological) $879.49
- RINVOQ (Biological) $828.13
- Humira (Biological) $753.79
- ORENCIA (Biological) $572.78
- TALTZ (Drug) $539.85
- SAPHNELO (Biological) $534.16
- EVENITY (Biological) $490.27
- AVSOLA (Biological) $406.80
- KEVZARA (Biological) $384.66
- Actemra (Biological) $372.48
- KRYSTEXXA (Biological) $367.82
- LUPKYNIS (Drug) $328.08
- KINERET (Drug) $310.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Denver
Dr. Aryeh Fischer, M.d, M.D
Rheumatology — Payments: $218,383
Rheumatology $218,383
Christopher Antolini, Md, MD
Rheumatology — Payments: $106,627
Rheumatology $106,627
Rennie Mccabe, Md, MD
Rheumatology — Payments: $76,484
Rheumatology $76,484
Barbara Goldstein, Md, MD
Rheumatology — Payments: $61,861
Rheumatology $61,861
Adam Berlinberg, Md, MD
Rheumatology — Payments: $41,589
Rheumatology $41,589
Vance Bray, Md, MD
Rheumatology — Payments: $35,851
Rheumatology $35,851